Furthermore, PRDX3 overexpression was strongly associated with the progression of hepatocellular carcinoma; patients with high serum PRDX3 levels had a shorter median survival time when compared to those with low serum PRDX3 level [59]. This evidence concerns the gene PRDX3 and hepatocellular carcinoma.